fda bpc-157 unapproved new drug warning letter As interest in weight loss medications and peptide therapies continues to grow, doctors are consumers about the risks associated with unregulated peptides that are increasingly being marketed online for weight loss Think twice before injecting peptides
Description
Mechanism in research literature The most-cited mechanistic finding is that BPC-157 activates the vascular endothelial growth factor receptor 2 (VEGFR2) in vascular endothelial cells (PMID 27847966)
When growth hormone then interacts with these upregulated receptors, it produces a dose-dependent and time-dependent increase in cell proliferation
Thin human safety record is part of a wider question many users ask, namely what a peptide overdose actually looks like and which compounds carry the most risk as doses climb
Long-term safety data: not available for any duration or route of administration in humans
